InfinixBio

The journey to regulatory approval requires expertise and precision. Our proprietary approach, the Rapid Innovate Model™, is a process designed to enhance our clients' success at pre-clinical and early-stage clinical phases to accelerate progress on the regulatory pathway. From discovery to regulatory approval, we provide comprehensive support to move your technology forward. #biotech #innovation #fda #clinicaltrials

🧬 The process of developing diagnostic tests involves navigating numerous technical and regulatory challenges. From initial concept to final approval, each phase demands a high level of expertise and coordination. We're interested in understanding where professionals in the field encounter the most significant obstacles. Your input will help identify critical areas for improvement, driving advancements in the way we approach diagnostic test development. #Diagnostics #Biotech #RegulatoryCompliance #InfinixBio

InfinixBio proudly partnered with a pioneering biotech firm to advance cancer treatment through a cutting-edge microbial-based immunotherapy platform targeting solid tumors. Our mission: to develop a bacterial strain capable of precise tumor localization and effective therapeutic delivery. Key Highlights: 🧬 Engineered bacterial strains using precision genome editing. 🔬 Ensured targeted delivery to the tumor microenvironment. 📊 Reduced development risks, leading to a Phase 1 clinical trial of the lead drug candidate. Read the full case study to learn more about our innovative approach and impactful results. https://lnkd.in/deZ3Fzvh

At InfinixBio, collaboration is more than a partnership—it’s the driving force behind innovation. We team up with visionary biotech firms, forward-thinking consultants, and dynamic pharmaceutical companies to push the boundaries of what’s possible in healthcare. Here’s how we make it happen: 🔬 Immunogenicity Expertise: We identify and mitigate immune responses to ensure your biologic therapies succeed. 🧬 Precision Biomarker Analysis: Our advanced techniques unlock insights that personalize patient care and enhance treatment outcomes. 🧪 Comprehensive Preclinical Studies: From concept to clinic, we provide the rigorous research needed to bring new therapies to life. Every project we undertake is guided by our commitment to excellence and a shared goal of transforming patient care.

At InfinixBio, we’re advancing cancer treatment by supporting labs and researchers with cutting-edge diagnostic tools and expertise. While traditional methods like radiation and chemotherapy have extended patient survival, they often fall short of providing a full cure. That’s why we focus on leveraging the body’s immune system through immunotherapy, working closely with partners in the field. Our team’s deep knowledge in assay development, immune cell research, and genetic engineering plays a vital role in helping other labs unlock new possibilities in cancer diagnostics and treatment. If you want to learn more about our work, visit https://lnkd.in/dSVrveMQ #CancerResearch #Immunotherapy #Biotech #CancerDiagnostics #InfinixBio #InnovationInMedicine #GeneticEngineering #AssayDevelopment #HealthcareInnovation

Understanding the complexities of biologic therapies means going beyond the data. It’s about having a partner who truly grasps the nuances of immunogenicity testing and is committed to guiding you through each step with care and precision. With a focus on tailored solutions and clear communication, we’re here to support your journey toward safer, more effective therapies. Connect with us today to explore how we can support your next project. #Biotech #Immunogenicity #TherapeuticDevelopment #InfinixBio

Alzheimer’s challenges millions globally, impacting individuals and their loved ones. On World Alzheimer’s Day, we highlight the importance of research and collaboration in the fight against this disease. At InfinixBio, we’re proud to work alongside others, contributing to advancements that aim to slow its progression and improve the quality of life for those affected. Together, we can make meaningful strides toward better treatments. #WorldAlzheimersDay #InfinixBio

At InfinixBio, we understand the complexities involved in bringing new therapies to market. That’s why we’ve developed the Rapid Innovate Model™—a process focused on anticipating challenges and ensuring a clear path through regulatory hurdles. Our model is built on the expertise of a dedicated team, committed to transforming innovative ideas into approved therapies. By leveraging over 50 patents and a deep understanding of regulatory processes, we’re not just navigating the journey—we’re redefining it. #TherapeuticDevelopment #BiotechInnovation #RegulatoryStrategy #InfinixBio

Meet Debbie Miliauskas-Henderson, our dynamic Operations Manager and HR leader at InfinixBio, featured in this month's spotlight. With a degree in Quantitative Business Analysis from Penn State and a wealth of experience across various industries, Debbie has been a key force behind our success. Her efforts, from crafting our benefits package to optimizing operations in HR, finance, and recruitment, have played a crucial role in building the culture we’re proud of. We’re grateful for Debbie’s dedication and expertise, which continue to drive InfinixBio forward!

As we observe Leukemia and Lymphoma Awareness Month, we reflect on the ongoing fight against these cancers. While survival rates have reached 72%, there is still more work to be done. Since its designation in 2017, this month has focused on raising awareness and supporting critical research. With over 60,000 new leukemia cases each year, early detection and continued research are key. At InfinixBio, we are proud to collaborate with others in advancing research efforts that aim to improve the quality of life for cancer survivors. Together, we contribute to the vital work needed to combat leukemia and lymphoma. Join us in raising awareness this September. #LeukemiaAwareness #LymphomaAwareness #CancerResearch